Cytokinetics | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 182.88M 30.27M 2024-03
Amgen USD 4.25B 837M 2024-03
Bayer EUR 8.3B 926M 2024-03
Biogen USD 1.75B 19.7M 2024-03
Bristol-Myers Squibb USD 8.93B 163M 2024-03
Eisai JPY 138.82B 1.37B 2023-12
Eli Lilly USD 7.09B 470.9M 2024-03
Exelixis USD 403.97M 49.18M 2024-03
Halozyme Therapeutics USD 167.55M 10.19M 2024-03
Intra Cellular Therapies USD 134.94M 13.55M 2024-03
Ionis Pharmaceuticals USD 117.35M 204.1M 2024-03
Ligand Pharmaceuticals USD 28.1M 1.64M 2024-03
Merck USD 12.24B 945M 2024-03
Novartis USD 9.02B 235M 2024-03
Pfizer USD 11.5B 3.92B 2024-03
Regeneron Pharmaceuticals USD 2.71B 206.1M 2024-03
Roche Holding CHF 22.16B 123M 2023-06
Sanofi EUR 7.68B 1.18B 2024-03



Cytokinetics Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.